Forecast for Vaccine Stocks After Coronavirus Pandemic Passes
Stephen Gardner, director at ETF Managers Group, explains why investors shouldn't be rushing to sell vaccine stocks like Moderna or BioNTech even as the spread of COVID-19 slows down.
More Videos
Inside the Exoskeleton Clinic Helping People Walk Again
Wandercraft's latest AI-powered exoskeletons help patients walk again. Could this device soon replace the wheelchair?
Lovable Raises $400 Million, Now A $13.3 Billion Valuation
Europe’s Lovable has raised $400 million in a Series C round, valuing the vibe-coding startup at a staggering $13.3 billion.
The Betting Boom Is Changing How Americans Watch Sports
Sports betting is booming as prediction markets reshape the industry. Past The Wire's Frank Zaccanelli breaks down what’s next for fans and investors.
This Wearable Robot Could Change the Way We Walk
Wearable robotics are moving beyond sci-fi. Dephy CEO Luke Mooney explains how its smart ankle exoskeleton is changing mobility, recovery and everyday movement.
SoundHound’s AI Is Talking to Your Car, Your Restaurant and More
Voice AI is moving into cars, restaurants and customer service. SoundHound CEO Keyvan Mohajer explains the company’s growth and the future of voice-powered AI.
Crypto Regulation Hangs in the Balance: What Happens Next?
Crypto markets are cooling as the Senate pushes the CLARITY Act vote, putting the industry’s regulatory future back in the spotlight.
